Signum Surgical, maker of the BioHealx implant system, announced today that it appointed Carol Burns as its new CEO.
Signum Surgical, (‘Signum’ or ‘the Company’) the medical technology company developing innovative solutions to treat ...
Pivotal milestone follows U.S. FDA De Novo clearance for BioHealx® in 2024. Signum Surgical, (‘Signum’ or ‘the Company’) the medical technology company developing innovative solutions to ...